Dr. Shimon Hassin
Chief Operating Officer
Biotechnology
BiondVax Pharmaceuticals Ltd.
Israel
Biography
Dr. Shimon Hassin has over 10 years of experience in Biotechnology, with specific expertise in the development of biopharmaceuticals. Prior to joining the company, Dr. Hassin was co-founder and CEO of Kadimastem, an embryonic stem cell company developing an artificial pancreas for curing Juvenile Diabetes. Before joining BiondVax, he worked at InSight Biopharmaceuticals, a leading Israeli biotechnology company active in the area of Biogenerics. In his capacity as Head of Process Development he was responsible for the manufacturing of a variety of Biogenerics such as therapeutic antibodies, cytokines and hormones. Dr. Hassin holds a Ph.D. in Biotechnology from the University of Maryland Biotechnology Institute and was a post-doctoral associate at the University of Bergen Center of Marine Biotechnology.
Research Interest
Biotechnology
